Overview

An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type Psoriasis

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This is a study of a new oral drug used for the treatment of psoriasis. All subjects will get active medication, there is no placebo arm.
Phase:
Phase 2
Details
Lead Sponsor:
Stiefel, a GSK Company
Treatments:
R 115866